SEC Tracker
Get the app

AIM ImmunoTech AIM

Thomas K Equels (CEO & President) bought 12,751 AIM at $0.16, worth $2K

Form 4 on AIM ImmunoTech (AIM), filed with the SEC on Nov 9, 2026, 3:48 pm ET. Source: the filing on SEC EDGAR.

Form
4
Filed
Importance
Notable
  1. 12,751 common shares purchased at $0.158
  2. Total owned shares now 222,797
  3. Reporting person is CEO & President

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when AIM ImmunoTech files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.